CN111329044A - Composition for recovering patients with liver diseases - Google Patents

Abstract

The invention belongs to the technical field of formula foods for special medical purposes, and particularly relates to a composition for recovering patients with liver diseases, which comprises the following raw materials: whey protein, vegetable oil, maltodextrin, galacto-oligosaccharide, arginine, glutamine, compound mineral substances, compound vitamins and sweetener stevioside. The applicant obtains a basic nutritional composition meeting the requirements of patients with liver diseases through multiple clinical researches, the composition can not only supplement the nutrition of the patients with liver diseases, but also has a good protection effect on liver injury, and further researches show that the composition has a good improvement effect on the patients with liver injury and diabetes mellitus.

Description

Composition for recovering patients with liver diseases

Technical Field

The invention belongs to the technical field of formula foods for special medical purposes, and particularly relates to a composition for recovering patients with liver diseases.

Background

Liver diseases are common diseases and frequently encountered diseases in China, and can be generally divided into viral hepatitis, alcoholic liver diseases, drug-induced liver injury, fatty liver, liver cirrhosis, liver cancer and the like. The '2017 world hepatitis report' issued by world health organization of 21/4/2017 shows that about 3.25 million people are infected with chronic hepatitis B virus or hepatitis C virus worldwide. 2016 liver disease research report states that chronic hepatitis B causes over 33 million cancer-related deaths each year in China. The incidence of hepatitis C is second to that of hepatitis B, and accounts for 17.06 percent of the total incidence of viral hepatitis. The incidence of 'rich and noble diseases' such as alcoholic liver, fatty liver and the like is also improved year by year, and by the end of 2010, the incidence of the total non-alcoholic fatty liver disease in China is about 15%, the incidence of the non-alcoholic fatty liver disease in the first-line city is close to the developed country in the west and reaches 20% -30%, and the incidence of the fatty liver disease in the severely obese people reaches 61% -94%. According to the calculation, at least 2 hundred million people have fatty liver disease in China, and the number of people who convert fatty liver disease into hepatic fibrosis and hepatic cirrhosis is about 400-. The situation of alcoholic liver disease is very severe and can not be ignored, and by 2011, the conservative estimation is that the number of patients suffering from alcoholic liver disease in China is about 5000 ten thousand.

The liver, the most important substance in the body and the energy metabolism organ, plays an important role in the metabolism of sugar, lipid, protein, amino acid, vitamin, hormone and other substances. When liver is damaged by various reasons (viruses, alcohol, etc.), the energy metabolism of the body can be obviously changed. Therefore, patients with liver diseases are very likely to suffer from malnutrition. Ismail et al found in a 400-patient control study that Chronic Hepatitis C (CHC) patients had malnutrition prior to the development of cirrhosis. Mengqinghua et al found in the REE study of 142 Chronic Hepatitis B (CHB) patients: the incidence of malnutrition in CHB patients was 14.10%, with 15.49% of patients being hypermetabolized, 47.18% being normal, and 37.32% being hypometabolized. In the cirrhosis compensation phase, up to 50-80% of patients are complicated by malnutrition of different degrees. In the decompensation phase of cirrhosis, nearly 100% of patients are complicated by malnutrition. The causes of malnutrition in patients with liver disease include reduced food intake, reduced nutrient absorption, increased nutrient loss, high metabolic state, and insufficient synthesis. The degree of malnutrition in patients with liver disease directly affects the prognosis of the patient.

Therefore, the nutritional support is an important part of the comprehensive treatment of patients with liver diseases, and under the condition of ensuring that the carbohydrate is ingested to supply enough calories, the chronic hepatitis patients should be rich in protein and proper amount of fat, and simultaneously should not neglect to supplement proper amount of B vitamins and fat-soluble vitamins such as vitamin A, D, E and trace elements of calcium, magnesium, zinc, selenium and the like so as to supplement the loss of the trace nutrients caused by the damage of liver cells. Patients with liver cirrhosis, the European society for intestinal and intestinal nutrition (ESPEN) and the American society for intestinal and intestinal nutrition (ASPEN) both recommend a dietary intake pattern of few meals and more meals, preferably 4 to 6 meals per day. The energy intake standard is 35-40 kcal/kg/d), and the protein intake is 1.2-1.5 kcal/kg/d). For patients with liver failure, the protein is not suitable to be used as an energy supply substance, and is suitable to be used as a source supplement of a liver tissue repair substance, and the supply amount is 1.5-2.0 g/kg/d); 0.8-1.5 g/kg/d) of amino acid, and in severe hepatic encephalopathy, the branched chain amino acid is supplemented into veins, and the changes of indexes such as blood ammonia and the like are closely monitored, so that the nutrition supply scheme is adjusted at any time. Proper amount of B vitamins, vitamin A, C, D, E, K and minerals such as potassium, magnesium, calcium, zinc, phosphate, etc.

At present, the number of enteral nutrition products for patients with liver diseases in China is very small, and the patients with critical liver diseases are often accompanied by complications such as nephropathy and diabetes, and the enteral nutrition products are not considered in the formula of the existing products.

Disclosure of Invention

Based on the reasons, the applicant obtains a basic nutritional composition meeting the requirements of patients with liver diseases through multiple clinical researches, the composition can not only supplement the nutrition of the patients with liver diseases, but also has a good protection effect on liver injury, and further researches find that the composition also has a good improvement effect on the patients with liver injury and diabetes.

The special medical food of the invention is taken alone or in combination with other foods under the guidance of doctors or clinical dieticians. Is a formula food specially processed and prepared for meeting the special requirements of people with limited food intake, digestive absorption disorder, metabolic disorder or specific disease states on nutrients or diet. The special medical food is not a medicine, but is not a common food eaten by normal people, but is a formula food which is specially developed and produced according to scientific objective facts after a great deal of medical research of clinicians and nutriologists. When the target population cannot eat common diet or cannot meet the nutritional requirements of the target population with daily diet, the formula food for special medical purposes can be used as a nutritional supplement way to play a nutritional support role. The food cannot replace the therapeutic effect of the drug, and the product must not claim the prevention and treatment function of the disease.

The invention is realized by the following technical scheme.

The composition comprises the following raw materials in parts by weight: 20-30 parts of whey protein, 10-30 parts of vegetable oil, 40-60 parts of maltodextrin, 0.1-3 parts of galacto-oligosaccharide, 0.1-2 parts of arginine, 0.1-2 parts of glutamine, 2.8-4.2 parts of compound mineral, 0.28-0.42 part of compound vitamin and 0.01-0.1 part of sweetening agent stevioside.

The compound vitamin comprises vitamin A, vitamin D, vitamin E, vitamin K, and vitamin B₁Vitamin B₂Vitamin B₆Vitamin B₁₂Nicotinic acid, folic acid, pantothenic acid, vitamin C biotin and taurine.

The compound mineral comprises sodium, potassium, copper, magnesium, ferrum, zinc, manganese, calcium, phosphorus, iodine, chlorine, selenium and chromium.

The whey protein powder is hydrolyzed whey protein powder, and the protein content is more than 75%.

The vegetable oil is one or more of rapeseed oil, sunflower seed oil, palm oil, linseed oil and medium-chain triglyceride, wherein MCT: the weight ratio of LCT is 1: 1.

the MCT is medium chain triglyceride and the LCT is long chain triglyceride.

The preferable composition comprises the following raw materials in parts by weight: 22 parts of hydrolyzed whey protein, 23 parts of vegetable oil, 45 parts of maltodextrin, 3 parts of galacto-oligosaccharide, 1 part of arginine, 2 parts of glutamine, 3.5 parts of compound mineral substance, 0.35 part of compound vitamin and 0.06 part of stevioside.

The composition can be used for preparing product for improving malnutrition of patients with liver diseases.

The composition can be made into special medical food.

The preparation method of the special medical food comprises the following steps:

a. sieving the raw materials with 20 mesh sieve;

b. preparing materials: stevioside diluent powder: taking stevioside, and completely mixing with 0.1-1 part of maltodextrin; compound vitamin dilution powder: taking the compound vitamin, and completely mixing the compound vitamin with 2.8-4.2 parts of maltodextrin;

c. putting galacto-oligosaccharide, compound mineral, arginine, glutamine and stevioside diluted powder into a mixer to be completely mixed to obtain mixed powder 1;

d. mixing vegetable oil, vitamin complex diluent powder and the mixed powder 1, and uniformly mixing to obtain mixed powder 2;

e. and (3) completely mixing the residual maltodextrin with the mixed powder 2, and packaging to obtain the maltodextrin.

The sources of the raw materials and auxiliary materials are shown in the table 1.

TABLE 1 sources of the raw and auxiliary materials of the present invention

In order to improve the problem of insufficient protein of patients, hydrolyzed whey protein is particularly selected, and the whey protein is rich in small molecular peptides, complete in amino acids, reasonable in proportion, easy to absorb by a human body quickly, capable of reducing the burden of the liver and capable of effectively correcting the negative nitrogen balance of patients with liver diseases; secondly, the composition can promote the synthesis of skeletal muscle protein and prevent sarcopenia; finally, the protein is rich in branched chain amino acid, the branched chain amino acid can be metabolized by muscles, the concentration of the branched chain amino acid is increased, the liver burden is not increased, the branched chain amino acid and aromatic amino acid can competitively enter a blood brain barrier, and the prevention and treatment of hepatic encephalopathy are facilitated.

The invention adopts medium-chain glyceride and long-chain glyceride, and has reasonable proportion: and MCT: LCT ═ 1: 1; the MCT added can rapidly supply energy, correct complications such as fatty diarrhea and the like, and ensure the metabolism of essential fatty acid and the absorption of fat-soluble vitamins under the condition of hepatic insufficiency.

The invention strengthens fat-soluble vitamin A, D, K, vitamin B, calcium, iron, selenium and other minerals, and improves the deficiency of trace elements caused by liver dysfunction of hepatopaths. Particularly, by adding trivalent chromium, the insulin sensitivity can be effectively improved, so that the regulation of blood sugar is achieved.

The galactooligosaccharides with strong probiotic capability are added, so that the intestinal microorganisms are added, the intestinal peristalsis is promoted, and the ammonia is discharged.

The invention particularly adds glutamine to prevent hepatic encephalopathy; arginine can promote ornithine circulation and reduce blood ammonia.

The invention relates to a formula food with special medical application designed for the population of patients with liver diseases, which is prepared by adding vitamins, minerals or other nutritional ingredients into whey protein, vegetable oil, amino acid and the like and processing the whey protein, the vegetable oil, the amino acid and the like by physical means to meet the requirements of patients with liver diseases with malnutrition or nutritional risks on various nutritional ingredients, and further researches show that the formula food has good improvement effect on the patients with diabetes.

The composition is an organic composition, is an organic whole obtained by a plurality of creative tests in clinical research, is not simply added and combined, has effects on improving the nutritional status of patients with liver diseases and promoting liver recovery, and is also effective on patients with combined diabetes through creative test 1, namely the composition is not simply added but is an organic composition obtained through creative tests.

DETAILED DESCRIPTION OF EMBODIMENT (S) OF INVENTION

The technical solutions of the present invention are described below with specific examples, but the scope of the present invention is not limited thereto.

The embodiments described in this specification are merely illustrative of implementations of the inventive concept and the scope of the present invention should not be considered limited to the specific forms set forth in the embodiments but rather by the equivalents thereof as may occur to those skilled in the art upon consideration of the present inventive concept. While the following embodiments of the invention have been described, the invention is not limited to the specific embodiments and applications described above, which are intended to be illustrative, instructive, and not limiting. Those skilled in the art, having the benefit of this disclosure, may effect numerous modifications thereto without departing from the scope of the invention as defined by the appended claims.

The following tests are conclusion tests of research personnel based on multiple creative tests and on the technical scheme to be protected by the invention. In the quantitative tests in the following examples, three replicates were set, and the data are the mean or the mean ± standard deviation of the three replicates.

The following experiments were performed by the applicant's assigned Longyu Yao (Beijing) science and technology, Inc.

Test 1

Influence on liver damage caused by diabetes

Test groups:

test 1 group: 22g of hydrolyzed whey protein, rapeseed oil, sunflower seed oil, 23g of medium chain triglyceride (MCT: LCT weight ratio is 1: 1), 45g of maltodextrin, 3g of galacto-oligosaccharide, 1g of arginine, 2g of glutamine, 3.5g of compound mineral, 0.35g of compound vitamin and 0.06g of stevioside; mixing completely.

Test 2 groups: 45g of maltodextrin, 3g of galacto-oligosaccharide, 1g of arginine, 2g of glutamine, 3.5g of compound mineral, 0.35g of compound vitamin and 0.06g of stevioside; mixing completely.

The test method comprises the following steps: SD male rats with the weight of 200 +/-10 g are taken, experimental animals are always raised in a clean animal room, the conditions of constant temperature of 25 ℃ and constant humidity of 70% are stable, and the light and shade alternation is kept for 12 hours. After the experimental rats are fed with the basic feed for 7 days for adaptive feeding, 15 fasting (without water prohibition) animals are randomly selected for 12 hours, and fasting blood glucose is measured to serve as the basic blood glucose value of the animals in the batch. Then randomly classifying into cages, marking and weighing, and classifying into a normal control group and a model group. Feeding normal feed to a normal control group, feeding high-fat high-sugar feed to a model group (the formula of the high-fat high-sugar feed comprises 50% of basal feed, 20% of white granulated sugar, 16% of lard, 11% of casein, 1% of gelatin, 1% of cholesterol, 0.5% of cholate, 0.5% of mineral matter, 0.5% of vitamin, and fasting (without water) for 12h after 4 weeks, dissolving STZ in a sodium citrate-citric acid buffer solution with sterile pH of 4.2-4.5 and 0.1mol/L, wherein the injection concentration of the solution is 0.1g/L, injecting STZ (streptozotocin) 30mg/kg once per body weight into the abdominal cavity of a model group rat, measuring blood sugar after fasting (without water) for 12h after 7 days by injecting an equal amount of the buffer solution once per body weight into the normal control group, and randomly grouping the rats with blood sugar value of more than 16.7mmol/L according to the fasting blood sugar level of the model rat, namely a model control group, each test group and a pioglitazone hydrochloride group, and the experimental stage is started. During the period, the experimental animals are ensured to freely drink and eat water, and the mental status, the activity, the diet, the drinking water and the body hair color condition are observed every day. Feeding high-fat and high-sugar feed and distilled water to a model control group, feeding 3g/kg of a product to each test group by intragastric administration, feeding the high-fat and high-sugar feed, feeding 1.5mg/kg of pioglitazone hydrochloride by intragastric administration after 30 minutes, continuously taking 28 days, taking blood from a tail end vein after fasting (without water prohibition) for 12 hours after 28 days, and measuring the fasting blood glucose value by a glucometer; after the rats were sacrificed, organ index was measured, alanine Aminotransferase (ALT) and aspartate Aminotransferase (AST) were measured according to the kit instructions.

And (3) test results: see table.

TABLE 2 Effect on fasting plasma glucose in rats

Note: p <0.01 compared to normal control group, # P <0.05 compared to model control group.

The test summary is as follows: the above tests show that the blood sugar drop value is more after the composition and the pioglitazone hydrochloride are co-administered to the diabetic rats, which fully indicates that the composition is suitable for the diabetic patients.

TABLE 3 Effect on rat organs

Note: p <0.01 compared to normal control group; # P <0.01 and # P <0.05 compared to model control.

And (4) test conclusion: after the composition and the pioglitazone hydrochloride are simultaneously administered to diabetic rats, the body weight ratio model group is obviously increased, and the composition and the pioglitazone hydrochloride have obvious protective effect on liver injury and kidney injury.

TABLE 4 Effect on ALT and AST in rat serum

Note: p <0.01 compared to normal control group; # P <0.01 and # P <0.05 compared to model control.

The test summary is as follows: after the composition and the pioglitazone hydrochloride are simultaneously administered to rats, the composition has a good protective effect on liver injury.

Preparation examples

Example 1

2000g of whey protein, 1000g of vegetable oil, 4000g of maltodextrin, 10g of galacto-oligosaccharide, 10g of arginine, 10g of glutamine, 280g of compound mineral, 28g of compound vitamin and 1g of sweetening agent stevioside.

Wherein the vitamin complex comprises vitamin A, vitamin D, vitamin E, vitamin K, and vitaminsB₁Vitamin B₂Vitamin B₆Vitamin B₁₂Nicotinic acid, folic acid, pantothenic acid, vitamin C, biotin and taurine.

Wherein the compound mineral comprises sodium, potassium, copper, magnesium, ferrum, zinc, manganese, calcium, phosphorus, iodine, chlorine, selenium and chromium.

The whey protein powder is hydrolyzed whey protein powder, and the protein content is more than 75%.

Wherein the vegetable oil is sunflower oil, linseed oil and medium chain triglycerides, wherein MCT: the weight ratio of LCT is 1: 1.

the preparation method comprises the following steps:

a. sieving the raw materials with 20 mesh sieve;

b. preparing materials: stevioside diluent powder: taking stevioside, and completely mixing with 10g of maltodextrin; compound vitamin dilution powder: mixing the compound vitamin with 280g of maltodextrin completely;

c. putting galacto-oligosaccharide, compound mineral, arginine, glutamine and stevioside diluted powder into a mixer to be completely mixed to obtain mixed powder 1;

d. mixing vegetable oil, vitamin complex diluent powder and the mixed powder 1, and uniformly mixing to obtain mixed powder 2;

e. and (3) completely mixing the residual maltodextrin with the mixed powder 2, and packaging to obtain the maltodextrin.

Example 2

3000g of whey protein, 3000g of vegetable oil, 6000g of maltodextrin, 300g of galacto-oligosaccharide, 200g of arginine, 200g of glutamine, 420g of compound mineral, 42g of compound vitamin and 10g of sweetening agent stevioside.

Wherein the vitamin complex comprises vitamin A, vitamin D, vitamin E, vitamin K, and vitamin B₁Vitamin B₂Vitamin B₆Vitamin B₁₂Nicotinic acid, folic acid, pantothenic acid, vitamin C, biotin and taurine.

Wherein the compound mineral comprises sodium, potassium, copper, magnesium, ferrum, zinc, manganese, calcium, phosphorus, iodine, chlorine, selenium and chromium.

The whey protein powder is hydrolyzed whey protein powder, and the protein content is more than 75%.

Wherein the vegetable oil is palm oil, rapeseed oil and medium chain triglycerides, wherein MCT: the weight ratio of LCT is 1: 1.

the preparation method comprises the following steps:

a. sieving the raw materials with 20 mesh sieve;

b. preparing materials: stevioside diluent powder: taking stevioside, and completely mixing the stevioside with 100g of maltodextrin; compound vitamin dilution powder: mixing the compound vitamin with 420g of maltodextrin completely;

c. putting galacto-oligosaccharide, compound mineral, arginine, glutamine and stevioside diluted powder into a mixer to be completely mixed to obtain mixed powder 1;

d. mixing vegetable oil, vitamin complex diluent powder and the mixed powder 1, and uniformly mixing to obtain mixed powder 2;

e. and (3) completely mixing the residual maltodextrin with the mixed powder 2, and packaging to obtain the maltodextrin.

Example 3

2200g of hydrolyzed whey protein, 2300g of vegetable oil, 4500g of maltodextrin, 300g of galacto-oligosaccharide, 100g of arginine, 200g of glutamine, 350g of compound mineral, 35g of compound vitamin and 6g of stevioside.

Wherein the vitamin complex comprises vitamin A, vitamin D, vitamin E, vitamin K, and vitamin B₁Vitamin B₂Vitamin B₆Vitamin B₁₂Nicotinic acid, folic acid, pantothenic acid, vitamin C, biotin and taurine.

Wherein the compound mineral comprises sodium, potassium, copper, magnesium, ferrum, zinc, manganese, calcium, phosphorus, iodine, chlorine, selenium and chromium.

The whey protein powder is hydrolyzed whey protein powder, and the protein content is more than 75%.

Wherein the vegetable oil is rapeseed oil, sunflower seed oil and medium chain triglycerides, wherein MCT: the weight ratio of LCT is 1: 1.

the preparation method comprises the following steps:

a. sieving the raw materials with 20 mesh sieve;

b. preparing materials: stevioside diluent powder: taking stevioside, and completely mixing the stevioside with 60g of maltodextrin; compound vitamin dilution powder: taking the compound vitamin, and completely mixing the compound vitamin with 350g of maltodextrin;

c. putting galacto-oligosaccharide, compound mineral, arginine, glutamine and stevioside diluted powder into a mixer to be completely mixed to obtain mixed powder 1;

d. mixing vegetable oil, vitamin complex diluent powder and the mixed powder 1, and uniformly mixing to obtain mixed powder 2;

e. and (3) completely mixing the residual maltodextrin with the mixed powder 2, and packaging to obtain the maltodextrin.

Example 4

2305g of hydrolyzed whey protein, 2405g of vegetable oil, 4605g of maltodextrin, 315g of galacto-oligosaccharide, 110g of arginine, 205g of glutamine, 365g of compound mineral, 38g of compound vitamin and 6.6g of stevioside.

Wherein the vitamin complex comprises vitamin A, vitamin D, vitamin E, vitamin K, and vitamin B₁Vitamin B₂Vitamin B₆Vitamin B₁₂Nicotinic acid, folic acid, pantothenic acid, vitamin C, biotin and taurine.

Wherein the compound mineral comprises sodium, potassium, copper, magnesium, ferrum, zinc, manganese, calcium, phosphorus, iodine, chlorine, selenium and chromium.

The whey protein powder is hydrolyzed whey protein powder, and the protein content is more than 75%.

Wherein the vegetable oil is linseed oil, palm oil and medium chain triglycerides, wherein MCT: the weight ratio of LCT is 1: 1.

the preparation method comprises the following steps:

a. sieving the raw materials with 20 mesh sieve;

b. preparing materials: stevioside diluent powder: taking stevioside, and completely mixing the stevioside with 66g of maltodextrin; compound vitamin dilution powder: taking the compound vitamin, and completely mixing the compound vitamin with 380g of maltodextrin;

c. putting galacto-oligosaccharide, compound mineral, arginine, glutamine and stevioside diluted powder into a mixer to be completely mixed to obtain mixed powder 1;

d. mixing vegetable oil, vitamin complex diluent powder and the mixed powder 1, and uniformly mixing to obtain mixed powder 2;

e. and (3) completely mixing the residual maltodextrin with the mixed powder 2, and packaging to obtain the maltodextrin.

Example 5

Hydrolyzed whey protein 2035 g, vegetable oil 2395g, maltodextrin 4410g, galacto-oligosaccharide 325g, arginine 90g, glutamine 215g, compound mineral 340g, compound vitamin 38g and stevioside 6 g.

Wherein the vitamin complex comprises vitamin A, vitamin D, vitamin E, vitamin K, and vitamin B₁Vitamin B₂Vitamin B₆Vitamin B₁₂Nicotinic acid, folic acid, pantothenic acid, vitamin C, biotin and taurine.

Wherein the compound mineral comprises sodium, potassium, copper, magnesium, ferrum, zinc, manganese, calcium, phosphorus, iodine, chlorine, selenium and chromium.

The whey protein powder is hydrolyzed whey protein powder, and the protein content is more than 75%.

Wherein the vegetable oil is rapeseed oil, sunflower seed oil and medium chain triglycerides, wherein MCT: the weight ratio of LCT is 1: 1.

the preparation method comprises the following steps:

a. sieving the raw materials with 20 mesh sieve;

b. preparing materials: stevioside diluent powder: taking stevioside, and completely mixing the stevioside with 60g of maltodextrin; compound vitamin dilution powder: taking the compound vitamin, and completely mixing the compound vitamin with 380g of maltodextrin;

c. putting galacto-oligosaccharide, compound mineral, arginine, glutamine and stevioside diluted powder into a mixer to be completely mixed to obtain mixed powder 1;

d. mixing vegetable oil, vitamin complex diluent powder and the mixed powder 1, and uniformly mixing to obtain mixed powder 2;

e. and (3) completely mixing the residual maltodextrin with the mixed powder 2, and packaging to obtain the maltodextrin.

Comparative example 1

200g of hydrolyzed whey protein, 2300g of vegetable oil, 4500g of maltodextrin, 300g of galacto-oligosaccharide, 200g of glutamine, 350g of compound mineral substance, 35g of compound vitamin and 6g of stevioside.

Wherein the vitamin complex comprises vitamin A, vitamin D, vitamin E, vitamin K, and vitamin B₁Vitamin B₂Vitamin B₆Vitamin B₁₂Nicotinic acid, folic acid, pantothenic acid, vitamin C, biotin and taurine.

Wherein the compound mineral comprises sodium, potassium, copper, magnesium, ferrum, zinc, manganese, calcium, phosphorus, iodine, chlorine, selenium and chromium.

The whey protein powder is hydrolyzed whey protein powder, and the protein content is more than 75%.

Wherein the vegetable oil is rapeseed oil, sunflower seed oil and medium chain triglycerides, wherein MCT: the weight ratio of LCT is 1: 1.

the preparation method comprises the following steps:

a. sieving the raw materials with 20 mesh sieve;

b. preparing materials: stevioside diluent powder: taking stevioside, and completely mixing the stevioside with 60g of maltodextrin; compound vitamin dilution powder: taking the compound vitamin, and completely mixing the compound vitamin with 350g of maltodextrin;

c. putting galacto-oligosaccharide, compound mineral, glutamine and stevioside diluted powder into a mixer to be completely mixed to obtain mixed powder 1;

d. mixing vegetable oil, vitamin complex diluent powder and the mixed powder 1, and uniformly mixing to obtain mixed powder 2;

e. and (3) completely mixing the residual maltodextrin with the mixed powder 2, and packaging to obtain the maltodextrin.

Test 2

Protection effect on acute alcoholic liver injury of rat

Test compositions: example 3 and comparative example 1.

The test method comprises the following steps: the SPF-grade male SD rat of 6-8 weeks old has the body mass of 180-. From day 15, the composition was administered 1h later for the remaining groups except for the normal control group to which distilled water and maintenance diet were administered, and then the composition was administered 2 times with 50% ethanol gavage, 2 molding intervals of 6h, and high-fat diet feeding was continued for 7d, in order to show successful molding of the clinical manifestations and pathological changes of ALD: (1) changes in animal behavior occurred: listlessness, inappetence, loose stool, fluffy and lusterless fur, unstable walking, mouth scratching of the front paw and rigid action; (2) liver function index abnormality: the AST and ALT levels of the serum are obviously higher than those of a normal control group; (3) pathological dissection of animals: the liver surface has the changes of spots, swelling and the like; (4) pathological section: inflammatory infiltration of liver tissue or accumulation of fat droplets in hepatocytes, etc.

Fasting without water for 16h after the last model building, taking blood from abdominal aorta, separating serum, and measuring AST and ALT levels with full-automatic biochemical analyzer.

Before the rat is sacrificed, the mental state, the food intake, the excrement and urine, the body hair, the activity condition and the like of the rat are observed and recorded, the mass of the rat body is weighed and recorded, and the liver coefficient is calculated.

And (3) test results:

(1) the normal control group rats have no abnormal change in general conditions, the model group rats have gradually reduced food intake and water intake, and the phenomena of inappetence, loose stool, fluffy and lusterless fur, listlessness, unstable walking, mouth scratching of front claws, dull movements and the like begin to appear. The rats in the group of example 3 are generally better than the rats in the model group. The comparative example 1 group was observed to be inferior to the non-example 3 group.

(2) The influence on the body quality, liver index and serum AST and ALT levels of rats with acute alcoholic liver injury is shown in Table 5.

TABLE 5 Effect on body quality, liver index and serum AST and ALT levels in rats with acute alcoholic liver injury

Note: p <0.01, P <0.05 was compared to model groups.

And (4) test conclusion: the tests show that the composition has good protective effect on liver injury, can obviously improve weight, appetite, activity and the like, and test data show that the composition has extremely lower liver injury than a model group, and the protective effect on liver injury is reduced after the dosage of hydrolyzed whey protein is reduced and arginine is removed, so that the composition is an organic whole.

Claims (9)

1. The composition is characterized by comprising the following raw materials in parts by weight: 20-30 parts of whey protein, 10-30 parts of vegetable oil, 40-60 parts of maltodextrin, 0.1-3 parts of galacto-oligosaccharide, 0.1-2 parts of arginine, 0.1-2 parts of glutamine, 2.8-4.2 parts of compound mineral, 0.28-0.42 part of compound vitamin and 0.01-0.1 part of sweetening agent stevioside.

2. A composition according to claim 1, wherein said vitamin complex comprises vitamin A, vitamin D, vitamin E, vitamin K, vitamin B₁Vitamin B₂Vitamin B₆Vitamin B₁₂Nicotinic acid, folic acid, pantothenic acid, vitamin C, biotin and taurine.

3. A composition according to claim 1, wherein said complex minerals comprise sodium, potassium, copper, magnesium, iron, zinc, manganese, calcium, phosphorus, iodine, chlorine, selenium, chromium.

4. A composition as claimed in claim 1 wherein the whey protein powder is a hydrolyzed whey protein powder with a protein content > 75%.

5. A composition according to claim 1 wherein the vegetable oil is canola oil, sunflower oil, palm oil, linseed oil and medium chain triglycerides, wherein MCT: the weight ratio of LCT is 1: 1.

6. the composition according to claim 1, which comprises the following raw materials in parts by weight: 22 parts of hydrolyzed whey protein, 23 parts of vegetable oil, 45 parts of maltodextrin, 3 parts of galacto-oligosaccharide, 1 part of arginine, 2 parts of glutamine, 3.5 parts of compound mineral substance, 0.35 part of compound vitamin and 0.06 part of stevioside.

7. A composition according to any one of claims 1 to 6, characterized in that it is used for the preparation of a product for improving the malnutrition in patients with liver diseases.

8. A composition according to any one of claims 1 to 6, characterised in that it is prepared as a food for special medical use.

9. The composition of claim 8, wherein the food product is prepared by a method comprising:

a. sieving the raw materials with 20 mesh sieve;

b. preparing materials: stevioside diluent powder: taking stevioside, and completely mixing with 0.1-1 part of maltodextrin; compound vitamin dilution powder: taking the compound vitamin, and completely mixing the compound vitamin with 2.8-4.2 parts of maltodextrin;

c. putting galacto-oligosaccharide, compound mineral, arginine, glutamine and stevioside diluted powder into a mixer to be completely mixed to obtain mixed powder 1;

d. mixing vegetable oil, vitamin complex diluent powder and the mixed powder 1, and uniformly mixing to obtain mixed powder 2;

e. and (3) completely mixing the residual maltodextrin with the mixed powder 2, and packaging to obtain the maltodextrin.